| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Albert R Muslimov | |
| Alexander S Timin | |||
| Mikhail V Zyuzin | |||
| Oleksii O Peltek | |||
| P2860 | cites work | Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides | Q24649091 |
| Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters | Q26801319 | ||
| Therapeutic radionuclides in nuclear medicine: current and future prospects | Q26861998 | ||
| In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles | Q27342269 | ||
| Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans | Q28078378 | ||
| Theranostic Imaging of Yttrium-90 | Q28083044 | ||
| Radioimmunotherapy of human tumours | Q28088825 | ||
| A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 | ||
| Nanobodies: natural single-domain antibodies | Q28287268 | ||
| Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes | Q28384090 | ||
| Functionalized carbon nanotubes: biomedical applications | Q28389777 | ||
| Novel Preparation Methods of (52)Mn for ImmunoPET Imaging | Q28391928 | ||
| Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung | Q28394834 | ||
| Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer | Q30480617 | ||
| Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines. | Q30829681 | ||
| Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview | Q33226381 | ||
| Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response | Q33396676 | ||
| Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results | Q33409137 | ||
| Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer | Q70179227 | ||
| A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties | Q70408414 | ||
| Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen) | Q71027172 | ||
| Blood-pool imaging using technetium-99m-labeled liposomes | Q71261984 | ||
| High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy | Q73906840 | ||
| Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies | Q74204396 | ||
| Radioimmunotherapy with alpha-emitting nuclides | Q77182049 | ||
| Transfer of 131I and fluoresceinyl sialic acid derivatives into the oligosaccharide chains of IgG: a new method for site-specific labeling of antibodies | Q77925161 | ||
| Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting | Q83165400 | ||
| Reduced isotope dose and imaging time with a high-efficiency CZT SPECT camera | Q83995180 | ||
| Technetium-99m-labeled ceftizoxime loaded long-circulating and pH-sensitive liposomes used to identify osteomyelitis | Q84442470 | ||
| Preparation and in vivo evaluation of multifunctional ⁹⁰Y-labeled magnetic nanoparticles designed for cancer therapy | Q87421422 | ||
| Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma | Q88377400 | ||
| Noninvasive PET Imaging of T cells | Q88513880 | ||
| Radiolabeled Dendrimers for Nuclear Medicine Applications | Q88849351 | ||
| Photochemical Conjugation and One-Pot Radiolabelling of Antibodies for Immuno-PET | Q90269782 | ||
| Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals | Q90550172 | ||
| PET Imaging of Receptor Tyrosine Kinases in Cancer | Q90697923 | ||
| Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice | Q90858356 | ||
| Photoactive chelates for radiolabelling proteins | Q90861323 | ||
| Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders | Q92112851 | ||
| Holmium-166 Microsphere Radioembolization of Hepatic Malignancies | Q92893864 | ||
| MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications | Q38694171 | ||
| α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts | Q38715106 | ||
| Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? | Q38755295 | ||
| Microwave-assisted one-pot synthesis of N-succinimidyl-4[ ¹⁸F]fluorobenzoate ([¹⁸F]SFB). | Q38758264 | ||
| ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging | Q38783061 | ||
| Nanoparticles and radiotracers: advances toward radionanomedicine | Q38785806 | ||
| Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting. | Q38812258 | ||
| Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies | Q38816325 | ||
| Cerenkov Radiation Induced Photodynamic Therapy Using Chlorin e6-Loaded Hollow Mesoporous Silica Nanoparticles. | Q38818714 | ||
| Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Nonsmall Cell Lung Cancer | Q38839153 | ||
| Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas | Q38842358 | ||
| Radionuclide (131)I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer | Q38851594 | ||
| Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date | Q38853466 | ||
| Diabody Pretargeting with Click Chemistry In Vivo | Q38854910 | ||
| SPECT/CT Imaging of Pluronic Nanocarriers with Varying Poly(ethylene oxide) Block Length and Aggregation State | Q38907374 | ||
| Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics | Q38926681 | ||
| Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough? | Q38948546 | ||
| Dendrimers as Innovative Radiopharmaceuticals in Cancer Radionanotherapy. | Q38949555 | ||
| Clinically Approved Nanoparticle Imaging Agents | Q38979886 | ||
| A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer | Q38985097 | ||
| Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs | Q38996204 | ||
| 111In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues. | Q39077979 | ||
| HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution | Q39107744 | ||
| Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody | Q39151986 | ||
| Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer | Q39181509 | ||
| Affibody molecules as engineered protein drugs | Q39197528 | ||
| Pretargeted Imaging and Therapy | Q39421977 | ||
| Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. | Q39460702 | ||
| Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles | Q39645937 | ||
| In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT. | Q39692007 | ||
| Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. | Q39805654 | ||
| On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model. | Q39882876 | ||
| Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. | Q39959127 | ||
| Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. | Q39991878 | ||
| Vivid tumor imaging utilizing liposome-carried bimodal radiotracer | Q33636265 | ||
| Clinical Pharmacology and Translational Aspects of Bispecific Antibodies | Q33648086 | ||
| Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody | Q33686807 | ||
| Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors | Q33848266 | ||
| The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y. | Q33851546 | ||
| Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease | Q33870879 | ||
| Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo | Q33892020 | ||
| Cell-penetrating peptides: breaking through to the other side | Q34032300 | ||
| Tumor therapy with targeted atomic nanogenerators | Q34102138 | ||
| Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells | Q34168357 | ||
| 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice | Q34206802 | ||
| Intrinsically radiolabelled [(59)Fe]-SPIONs for dual MRI/radionuclide detection. | Q34228807 | ||
| Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek | Q34306896 | ||
| Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides | Q34314511 | ||
| Intrinsically radiolabeled nanoparticles: an emerging paradigm | Q34315359 | ||
| Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy | Q34324413 | ||
| Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex | Q34467985 | ||
| Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives | Q34473460 | ||
| Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter | Q34512455 | ||
| Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver | Q34563356 | ||
| Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging | Q34603395 | ||
| Engineered antibody fragments and the rise of single domains | Q34650980 | ||
| Radiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography | Q34764435 | ||
| Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma | Q34785007 | ||
| Current use and future potential of organometallic radiopharmaceuticals. | Q34979217 | ||
| Synthesis of fluorine-18 radio-labeled serum albumins for PET blood pool imaging | Q35084988 | ||
| Iodine-125-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent | Q35365860 | ||
| Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical Translation | Q35438759 | ||
| Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. | Q35537978 | ||
| Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). | Q35583369 | ||
| Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe | Q35590083 | ||
| A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer | Q35632475 | ||
| Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry | Q36179288 | ||
| False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. | Q36337288 | ||
| Radiolabeling strategies for tumor-targeting proteinaceous drugs | Q38189541 | ||
| Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors. | Q38198737 | ||
| Nanotubes in biological applications | Q38212048 | ||
| Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications | Q38226315 | ||
| Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. | Q38256388 | ||
| A nuclear chocolate box: the periodic table of nuclear medicine. | Q38269216 | ||
| Applications of polymer micelles for imaging and drug delivery | Q38356347 | ||
| Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery | Q38440916 | ||
| In vivo imaging with antibodies and engineered fragments. | Q38454458 | ||
| New Developments in Liposomal Drug Delivery | Q38502540 | ||
| Antibody-targeted biodegradable nanoparticles for cancer therapy | Q38665261 | ||
| Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging. | Q53339812 | ||
| Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles. | Q53413766 | ||
| Molecular design of radiocopper-labelled Affibody molecules. | Q55030086 | ||
| Rapid and Efficient Generation of Stable Antibody-Drug Conjugates via an Encoded Cyclopropene and an Inverse-Electron-Demand Diels-Alder Reaction. | Q55348656 | ||
| Porous Inorganic Carriers Based on Silica, Calcium Carbonate and Calcium Phosphate for Controlled/Modulated Drug Delivery: Fresh Outlook and Future Perspectives | Q57150783 | ||
| Nano based drug delivery systems: recent developments and future prospects | Q57154808 | ||
| Renal Clearable Luminescent Gold Nanoparticles: From Bench to Clinics | Q57161039 | ||
| Radiopharmaceutical enhancement by drug delivery systems: A review | Q57284631 | ||
| Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer | Q57295430 | ||
| Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors | Q57805470 | ||
| Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies | Q58147367 | ||
| Enzyme-Mediated Site-Specific Bioconjugation of Metal Complexes to Proteins: Sortase-Mediated Coupling of Copper-64 to a Single-Chain Antibody | Q60208292 | ||
| Successful imaging of human cancer with indium-111-labeled phospholipid vesicles | Q68484370 | ||
| Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes | Q40112405 | ||
| Are diamond nanoparticles cytotoxic? | Q40187520 | ||
| Development of (177)Lu-DOTA-Dendrimer and Determination of Its Effect on Metal and Ion Levels in Tumor Tissue | Q40254781 | ||
| Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments | Q40712585 | ||
| (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction | Q40777174 | ||
| Radioimmunotherapy: recent results and future directions | Q40945426 | ||
| Stable Radiolabeling of Sulfur-Functionalized Silica Nanoparticles with Copper-64 | Q41476720 | ||
| Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry | Q42105089 | ||
| The making of bispecific antibodies | Q42323236 | ||
| Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging | Q42556439 | ||
| Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation | Q42601023 | ||
| Technetium-99m-labeled poly(DL-lactide-co-glycolide) nanoparticles as an alternative for sentinel lymph node imaging. | Q42762234 | ||
| Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging | Q43062152 | ||
| Enzyme-Mediated Modification of Single-Domain Antibodies for Imaging Modalities with Different Characteristics | Q43080054 | ||
| (186)Re-maSGS-Z (HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours | Q43273260 | ||
| Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging | Q43283369 | ||
| Reduce, reuse and recycle: a green solution to Canada's medical isotope shortage | Q43310142 | ||
| Radiolabelled biodegradable microspheres for lung imaging | Q43434302 | ||
| PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography | Q43718606 | ||
| Synthesis and characterization of 111In-DTPA-N-TIMP-2: a radiopharmaceutical for imaging matrix metalloproteinase expression | Q43804729 | ||
| Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers | Q44287754 | ||
| Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer | Q44472217 | ||
| Nucleation and growth of gold nanoparticles studied via in situ small angle X-ray scattering at millisecond time resolution | Q44615429 | ||
| Thermoresponsive, hydrolytically degradable polymer micelles intended for radionuclide delivery. | Q45953560 | ||
| Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. | Q45986152 | ||
| 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer. | Q46097998 | ||
| Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats | Q46547092 | ||
| Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer | Q46852541 | ||
| Mono(pyridine-N-oxide) DOTA analog and its G1/G4-PAMAM dendrimer conjugates labeled with 177Lu: radiolabeling and biodistribution studies | Q46960181 | ||
| Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies | Q46983180 | ||
| Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review | Q47190264 | ||
| Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts | Q47631382 | ||
| Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu | Q47723600 | ||
| Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. | Q48192595 | ||
| PET Radiometals for Antibody Labeling. | Q48228929 | ||
| PET imaging with copper-64 as a tool for real-time in vivo investigations of the necessity for cross-linking of polymeric micelles in nanomedicine | Q48278064 | ||
| Water-soluble 99mTc-labeled dendritic novel porphyrins tumor imaging and diagnosis | Q49027224 | ||
| Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma. | Q49107699 | ||
| Bispecific antibodies: design, therapy, perspectives | Q49195146 | ||
| Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery. | Q49550152 | ||
| Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β--Particle, and Auger Electron Emitters. | Q50231495 | ||
| Holmium-loaded poly(L-lactic acid) microspheres: in vitro degradation study. | Q51167090 | ||
| Aligning physics and physiology: Engineering antibodies for radionuclide delivery. | Q51740406 | ||
| Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. | Q51750048 | ||
| Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation. | Q52098663 | ||
| Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets. | Q52765342 | ||
| Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. | Q52815685 | ||
| 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer. | Q52981848 | ||
| DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy. | Q53063188 | ||
| Radiosynthesis and initial evaluation of (18)F labeled nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. | Q53123501 | ||
| Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission. | Q53220333 | ||
| Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy. | Q53267635 | ||
| In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels. | Q53306641 | ||
| Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology | Q36339722 | ||
| An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy | Q36437102 | ||
| Exploiting the enhanced permeability and retention effect for tumor targeting | Q36578875 | ||
| Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging | Q36585770 | ||
| MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation | Q36586434 | ||
| Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. | Q36733054 | ||
| Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided 111In-labeled polymeric micelles | Q36766095 | ||
| Biodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP). | Q36783691 | ||
| Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging | Q36891102 | ||
| Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts | Q36939290 | ||
| Direct labeling of proteins with 99mTc | Q36942954 | ||
| Enhanced retention of the alpha-particle-emitting daughters of Actinium-225 by liposome carriers | Q36970476 | ||
| Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging | Q37010649 | ||
| Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. | Q37060054 | ||
| Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis | Q37070582 | ||
| Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells | Q37134529 | ||
| Principles of nanoparticle design for overcoming biological barriers to drug delivery | Q37162182 | ||
| Silica-based nanoprobes for biomedical imaging and theranostic applications. | Q37182903 | ||
| Alpha-particles for targeted therapy | Q37187007 | ||
| Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. | Q37207310 | ||
| Therapeutic radionuclides: biophysical and radiobiologic principles | Q37228877 | ||
| Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. | Q37318975 | ||
| Alternative Non-Antibody Protein Scaffolds for Molecular Imaging of Cancer | Q37394193 | ||
| Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles | Q37469888 | ||
| Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo | Q37519517 | ||
| Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68. | Q37631557 | ||
| Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers | Q37644203 | ||
| Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. | Q37730252 | ||
| Dendrimer toxicity: Let's meet the challenge. | Q37740264 | ||
| Peptide targeted copper-64 radiopharmaceuticals | Q37824340 | ||
| Human serum albumin conjugated biomolecules for cancer molecular imaging | Q37978359 | ||
| Carbon nanotube exploration in cancer cell lines | Q38009560 | ||
| Liposome imaging agents in personalized medicine | Q38043851 | ||
| Matching chelators to radiometals for radiopharmaceuticals | Q38156660 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 90 | |
| P577 | publication date | 2019-08-21 | |
| P1433 | published in | Journal of Nanobiotechnology | Q15752156 |
| P1476 | title | Current outlook on radionuclide delivery systems: from design consideration to translation into clinics | |
| P478 | volume | 17 |
| Q92392716 | Correction to: Current outlook on radionuclide delivery systems: from design consideration to translation into clinics | cites work | P2860 |
Search more.